Showing results (71-80 of 372) with videos related to
Sort By:
Pageof 38
Infectious Disease Clinics of North America|March 1, 1993
Risk factors for infective endocarditisJ M Steckelberg, W R WilsonClinical and Experimental Pharmacology & Physiology|November 1, 1995
Hypoxia-activated prodrugs as antitumour agents: strategies for maximizing tumour cell killingW R Wilson, F B PruijnMayo Clinic Proceedings|February 1, 1983
Tetracyclines, chloramphenicol, erythromycin, and clindamycinW R Wilson, F R CockerillJournal of Speech and Hearing Research|December 1, 1984
Masked and unmasked pure-tone thresholds of infants and adults: development of auditory frequency selectivity and sensitivityR J Nozza, W R WilsonMayo Clinic Proceedings|March 1, 1982
Symposium on infective endocarditis. III. Endocarditis due to gram-negative bacteria. Report of 56 casesJ E Geraci, W R WilsonHead & Neck Surgery|September 1, 1981
A method for combined dacryocystorhinostomy with external ethmoidectomyW R Wilson, A S GroveThe American Journal of Otology|October 1, 1980
Update on the use of streptomycin therapy for Meniere's diseaseW R Wilson, H F SchuknechtThe Journal of Pharmacy and Pharmacology|June 13, 1998
The design of selectively-activated anti-cancer prodrugs for use in antibody-directed and gene-directed enzyme-prodrug therapiesW A Denny, W R WilsonMayo Clinic Proceedings|October 1, 1987
Tetracyclines, chloramphenicol, erythromycin, and clindamycinW R Wilson, F R CockerillMayo Clinic Proceedings|April 1, 1985
Erythromycin: a microbial and clinical perspective after 30 years of clinical use (2)J A Washington, W R WilsonPageof 38